Autres langues Sanara MedTech Inc.

Actions

SMTI

US79957L1008

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 18/04/2024			Varia. 5j.	Varia. 1 janv.
34,01 ^USD	+7,63 %		+3,22 %	-17,25 %

05/04	Sanara MedTech nomme Jake Waldrop au poste de directeur de l'exploitation	MT
05/04	Sanara MedTech Inc. annonce des changements au sein de sa direction, à compter du 15 avril 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sanara MedTech Inc. Announces $55 Million Debt Facility	18/04
Sanara Medtech Inc. Announces $55 Million Debt Facility	18/04
Sanara MedTech Appoints Jake Waldrop as Chief Operating Officer	05/04
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer	05/04
Sanara MedTech Inc. Announces Executive Changes, Effective April 15, 2024	05/04
Earnings Flash (SMTI) SANARA MEDTECH Posts Q4 Revenue $17.7M, vs. Street Est of $16.5M	25/03
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results	25/03
Sanara MedTech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates	13/03
Sanara MedTech Reports Higher Preliminary Q4 Revenue	22/02
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023	22/02
Sanara MedTech Inc. Announces Unaudited Preliminary Net Revenue Results for the Fourth Quarter and Full-Year 2023	22/02
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides	03/01
Sanara MedTech Secures Exclusive Licensing Deal with Tufts University for 18 Collagen Peptides	03/01
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing	30/11
Sanara MedTech Q3 Loss Narrows, Revenue Rises; Shares Fall After Hours	13/11
Sanara MedTech Inc. Announces Third Quarter 2023 Results	13/11
Earnings Flash (SMTI) SANARA MEDTECH Reports Q3 Revenue $16M, vs. Street Est of $18.8M	13/11
Sanara MedTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates	30/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sanara MedTech Inc.

Actions

SMTI

US79957L1008

Autres langues

Filtres